0001968202-23-000039.txt : 20231108
0001968202-23-000039.hdr.sgml : 20231108
20231108160720
ACCESSION NUMBER: 0001968202-23-000039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231107
FILED AS OF DATE: 20231108
DATE AS OF CHANGE: 20231108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RYAN ARTHUR F
CENTRAL INDEX KEY: 0001187443
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 231387844
MAIL ADDRESS:
STREET 1: CITIZENS FINANCIAL GROUP, INC
STREET 2: 600 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2023-11-07
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001187443
RYAN ARTHUR F
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
1
Common Stock
2023-11-07
4
S
0
6
824.59
D
18641
D
Common Stock
2023-11-07
4
S
0
18
825.53
D
18623
D
Common Stock
2023-11-07
4
S
0
4
826.58
D
18619
D
Common Stock
2023-11-07
4
S
0
11
827.65
D
18608
D
Common Stock
2023-11-07
4
S
0
39
828.54
D
18569
D
Common Stock
2023-11-07
4
S
0
18
829.43
D
18551
D
Common Stock
2023-11-07
4
S
0
3
830.39
D
18548
D
Common Stock
2023-11-07
4
S
0
1
838.46
D
18547
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.
Represents volume-weighted average price of sales of 6 shares of Company stock on November 7, 2023 at prices ranging from $824.14 to $824.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
Represents volume-weighted average price of sales of 18 shares of Company stock on November 7, 2023 at prices ranging from $825.04 to $825.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
Represents volume-weighted average price of sales of 4 shares of Company stock on November 7, 2023 at prices ranging from $826.44 to $826.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
Represents volume-weighted average price of sales of 11 shares of Company stock on November 7, 2023 at prices ranging from $827.03 to $827.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
Represents volume-weighted average price of sales of 39 shares of Company stock on November 7, 2023 at prices ranging from $828.01 to $828.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
Represents volume-weighted average price of sales of 18 shares of Company stock on November 7, 2023 at prices ranging from $829.10 to $829.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
Represents volume-weighted average price of sales of 3 shares of Company stock on November 7, 2023 at prices ranging from $830.04 to $830.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2023 at each separate price.
/s/**Arthur F. Ryan
2023-11-08